Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
FDA Approvals
FDA Approvals
Behind-the-Counter Drug Access
Mark Senak, JD
Read More
FDA Approvals
Approvable Letters in 2007 and the Outlook for 2008
Mark Senak, JD
Read More
FDA Approvals
Heparin at the Center of the Storm
Mark Senak, JD
Read More
FDA Approvals
Potayto—Potahto? The Meaning of the FDA's "Complete Response" Letters
Mark Senak, JD
Read More
FDA Approvals
The Obama Administration and the FDA
Mark Senak, JD
Read More
FDA Approvals
New Reporting System for Potential Safety Concerns of Drugs on the Market
Mark Senak, JD
Read More
FDA Approvals
The Cardiovascular Pipeline: ACC 2010 Features Late-Stage Drugs
Wayne Kuznar
Read More
FDA Approvals
Promising New Approaches to Multiple Sclerosis Medications: AAN 2010
Alice Goodman
Read More
FDA Approvals
GI Drugs in Late Development: DDW 2010
Alice Goodman
Read More
FDA Approvals
The Cardiology Pipeline
Wayne Kuznar
Read More
49
50
51
52
53
Page 52 of 53
Results 511 - 520 of 522